Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia
Sponsor: Inogen Inc.
Listed as NCT06000332, this NA trial focuses on Nocturnal Hypoxemia and remains completed. Sponsored by Inogen Inc., it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Nov 2023 — Feb 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Inogen Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Statesville, United States